There's a lot take in on this chart. Clearly the is higher than it has ever been in the last six months. The reason for that is that the FDA has approved the drug that the company is working on to move on to the next phase. That sounds great but then how come it didn't move back to where it was six months ago? Well because that it did not go back to its past average, I predict that this hype is over and now is a good time to short.